Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients
Recruiting · NCT07573059 · Registry updated 2026-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, arginase deficiency, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, urea cycle disorder | Recruiting | Not applicable | 2026-05-07 | NCT07573059 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Immedica Pharma US Inc | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rare Disease Research | Atlanta | United States | 1 |